Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Characteristic of the transcriptomics in the early subcortical vascular cognitive impairment

ABSTRACT: Characteristic of the transcriptomics in the early subcortical vascular cognitive impairment

PROVIDER: PRJNA831854 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR18915600_1.fastq.gz	Fastqsanger.gz
	SRR18915600_2.fastq.gz	Fastqsanger.gz
	SRR18915601_1.fastq.gz	Fastqsanger.gz
	SRR18915601_2.fastq.gz	Fastqsanger.gz
	SRR18915602_1.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 80

Similar Datasets

Characteristic of the transcriptomics in the early subcortical vascular cognitive impairment [RNA-Seq]

Project description:Characteristic of the transcriptomics in the early subcortical vascular cognitive impairment [RNA-Seq]

| PRJNA831858 | ENA

Characteristic of the transcriptomics in the early subcortical vascular cognitive impairment [miRNA-Seq]

Project description:Characteristic of the transcriptomics in the early subcortical vascular cognitive impairment [miRNA-Seq]

| PRJNA831859 | ENA

Characteristic of the transcriptomics in the early subcortical vascular cognitive impairment [miRNA-Seq]

Project description:Two cohorts with cerebrovascular disease are included in the present study, i.e., SCD group and VCI group. Participants in SVD group has the normal cognitive function and others in VCI group show the worse cognitive function. The whole-blood is collected from each participant, and RNA sequencing is conducted in whole-blood samples. Characteristic of circRNA, lncRNA, miRNA and mRNA are identified in the present blood samples.

2022-04-28 | GSE201481 | GEO

Characteristic of the transcriptomics in the early subcortical vascular cognitive impairment [RNA-Seq]

2022-04-28 | GSE201482 | GEO

Characteristic of the transcriptomics in the early subcortical vascular cognitive impairment

Project description:This SuperSeries is composed of the SubSeries listed below.

2022-04-28 | GSE201483 | GEO

Immunotherapy-related cognitive impairment after CAR T cell therapy in mice

Project description:Persistent central nervous system (CNS) immune dysregulation and consequent dysfunction of multiple neural cell types is central to the neurobiological underpinnings of a cognitive impairment syndrome, colloquially referred to as “brain fog”, that can occur following traditional cancer therapies or certain infections. Immunotherapies have revolutionized cancer care for many tumor types, but the potential long-term cognitive sequelae are incompletely understood. Here, we demonstrate in mouse models that chimeric antigen receptor (CAR) T-cell therapy for both CNS and non-CNS cancers can impair cognitive function and induce a persistent CNS immune response characterized by white matter microglial reactivity, microglial chemokine expression, and elevated cerebrospinal fluid (CSF) cytokines and chemokines. Consequently, oligodendroglial homeostasis and hippocampal neurogenesis are disrupted. Single nucleus sequencing studies of human frontal cortex and subcortical white matter from brain tumor patients with or without previous CAR T-cell therapy confirm reactive states of microglia and oligodendrocytes in patients treated with CAR T cell therapy. In mice, transient microglial depletion or CCR3 chemokine receptor blockade rescues oligodendroglial deficits and cognitive performance in a behavioral test of attention and short-term memory function following CAR T-cell therapy. Taken together, these findings illustrate similar mechanisms underlying immunotherapy-related cognitive impairment (IRCI) and cognitive impairment following traditional cancer therapies and other immune challenges.

2025-02-18 | GSE286221 | GEO

Ginsenoside CK improves cognitive impairment

Project description:Ginsenoside CK improves cognitive impairment

| PRJNA916218 | ENA

Immunotherapy-related cognitive impairment after CAR T cell therapy in mice [scRNA-seq]

2025-02-18 | GSE287125 | GEO

Identification of different miRNAs in Alzheimer's disease and vascular cognitive impairment and dementia

Project description:Identification of different miRNAs in Alzheimer's disease and vascular cognitive impairment and dementia

| PRJNA904393 | ENA

Human amnion epithelial cell therapy reduces hypertension-induced vascular stiffening and cognitive impairment

Project description:Human amnion epithelial cell therapy reduces hypertension-induced vascular stiffening and cognitive impairment

| PRJNA1041469 | ENA